Form 4 for MBIO MUSTANG BIO, INC.
Accepted 2026-04-27 16:05:20 ET · period of report 2026-04-24 · accession 0001104659-26-049430 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-27 16:05 | 2026-04-24 | MBIO | Litchman Manuel MD | Pres, CEO, Interim CFO, Dir | F - Tax | $0.75 | -19 | 1,615 | -1% | -$14.25 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2026-04-24 | F | D | 19 | $0.75 | 1,615 | D | — | — | (F1) 19 shares of common stock were relinquished to cover tax liability associated with the delivery of shares of common stock upon the vesting of restricted stock units. |